
Reset all filters
01 1Macleods Pharmaceuticals Limited
02 1PFIZER ITALIA Srl
03 1Pfizer
04 1Pfizer AG
Reset all filters
01 3Rifabutin
02 1rifabutin
Reset all filters
01 1CAPSULE
02 1Caps
03 1HARD CAPSULES
04 1Rifabutin 150Mg 30 Joined' Oral Use
Reset all filters
01 1Italy
02 1Sweden
03 1Switzerland
04 1United Kingdom
Reset all filters
01 1Ansatipin
02 2Mycobutin
03 1Blank
Regulatory Info : Generic
Registration Country : United Kingdom
Brand Name :
Dosage Form : CAPSULE
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number : 50689
Regulatory Info : Generic
Registration Country : United Kingdom
Regulatory Info :
Registration Country : Sweden
Brand Name : Ansatipin
Dosage Form : HARD CAPSULES
Dosage Strength : 150 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Mycobutin
Dosage Form : Rifabutin 150Mg 30 Joined' Oral Use
Dosage Strength : 30 cps 150 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Switzerland
Brand Name : Mycobutin
Dosage Form : Caps
Dosage Strength : 150mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland